CompanyRDYNYSEHyderabad

Dr Reddys Laboratories Ltd

SEC EDGAR ClinicalTrials.gov drreddys.com

6-KSep 22Latest SEC filing, period to Sep 22

Jul 22Latest story

July 2026

Dr. Reddy's records Rs.2,397 million provision for out-of-spec semaglutide

Jul 22Quarterly updateDr Reddys Laboratories Ltd semaglutide